AAAAAA

   
Results: 1-16 |
Results: 16
Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein
Authors: Cha, JHJ Farrell, LA Ahmed, SF Frey, A Hsiao-Ashe, KK Young, AB Penney, JB Locascio, JJ Hyman, BT Irizarry, MC
Citation: Jhj. Cha et al., Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein, NEUROBIOL D, 8(1), 2001, pp. 90-102
Uptake of fibrillar beta-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice
Authors: Chung, HY Brazil, MI Irizarry, MC Hyman, BT Maxfield, FR
Citation: Hy. Chung et al., Uptake of fibrillar beta-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice, NEUROREPORT, 12(6), 2001, pp. 1151-1154
Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: Implications for neural system disruption
Authors: Le, R Cruz, L Urbanc, B Knowles, RB Hsiao-Ashe, K Duff, K Irizarry, MC Stanley, HE Hyman, BT
Citation: R. Le et al., Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: Implications for neural system disruption, J NE EXP NE, 60(8), 2001, pp. 753-758
Alzheimer disease therapeutics
Authors: Irizarry, MC Hyman, BT
Citation: Mc. Irizarry et Bt. Hyman, Alzheimer disease therapeutics, J NE EXP NE, 60(10), 2001, pp. 923-928
Elevation of cystatin C in susceptible neurons in Alzheimer's disease
Authors: Deng, A Irizarry, MC Nitsch, RM Growdon, JH Rebeck, GW
Citation: A. Deng et al., Elevation of cystatin C in susceptible neurons in Alzheimer's disease, AM J PATH, 159(3), 2001, pp. 1061-1068
beta-site APP cleaving enzyme mRNA expression in APP transgenic mice - Anatomical overlap with transgene expression and static levels with aging
Authors: Irizarry, MC Locascio, JJ Hyman, BT
Citation: Mc. Irizarry et al., beta-site APP cleaving enzyme mRNA expression in APP transgenic mice - Anatomical overlap with transgene expression and static levels with aging, AM J PATH, 158(1), 2001, pp. 173-177
Alzheimer's disease
Authors: Irizarry, MC Hyman, BT
Citation: Mc. Irizarry et Bt. Hyman, Alzheimer's disease, PRINCIPLES OF NEUROEPIDEMIOLOGY, 2001, pp. 69-98
Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies
Authors: Sharma, N McLean, PJ Kawamata, H Irizarry, MC Hyman, BT
Citation: N. Sharma et al., Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies, ACT NEUROP, 102(4), 2001, pp. 329-334
Apolipoprotein E facilitates neuritic and cerebrovascular plaque formationin an Alzheimer's disease model
Authors: Holtzman, DM Fagan, AM Mackey, B Tenkova, T Sartorius, L Paul, SM Bales, K Ashe, KH Irizarry, MC Hyman, BT
Citation: Dm. Holtzman et al., Apolipoprotein E facilitates neuritic and cerebrovascular plaque formationin an Alzheimer's disease model, ANN NEUROL, 47(6), 2000, pp. 739-747
Age-related amyloid beta deposition in transgenic mice overexpressing bothAlzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss (vol 157, pg 331, 2000)
Authors: Takeuchi, A Irizarry, MC Duff, K Saido, TC Ashe, KH Hasegawa, M Mann, DMA Hyman, BT Iwatsubo, T
Citation: A. Takeuchi et al., Age-related amyloid beta deposition in transgenic mice overexpressing bothAlzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss (vol 157, pg 331, 2000), AM J PATH, 157(4), 2000, pp. 1413-1413
Age-related amyloid beta deposition in transgenic mice overexpressing bothAlzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss
Authors: Takeuchi, A Irizarry, MC Duff, K Saido, TC Ashe, KH Hasegawa, M Mann, DMA Hyman, BT Iwatsubo, T
Citation: A. Takeuchi et al., Age-related amyloid beta deposition in transgenic mice overexpressing bothAlzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss, AM J PATH, 157(1), 2000, pp. 331-339
alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining
Authors: Gomez-Tortosa, E Newell, K Irizarry, MC Sanders, JL Hyman, BT
Citation: E. Gomez-tortosa et al., alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining, ACT NEUROP, 99(4), 2000, pp. 352-357
Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice
Authors: Irizarry, MC Cheung, BS Rebeck, GW Paul, SM Bales, KR Hyman, BT
Citation: Mc. Irizarry et al., Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice, ACT NEUROP, 100(5), 2000, pp. 451-458
Risperidone treatment of behavioral disturbances in outpatients with dementia
Authors: Irizarry, MC Ghaemi, SN Lee-Cherry, ER Gomez-Isla, T Binetti, G Hyman, BT Growdon, JH
Citation: Mc. Irizarry et al., Risperidone treatment of behavioral disturbances in outpatients with dementia, J NEUROP CL, 11(3), 1999, pp. 336-342
Clinical and quantitative pathologic correlates of dementia with Lewy bodies
Authors: Gomez-Tortosa, E Newell, K Irizarry, MC Albert, M Growdon, JH Hyman, BT
Citation: E. Gomez-tortosa et al., Clinical and quantitative pathologic correlates of dementia with Lewy bodies, NEUROLOGY, 53(6), 1999, pp. 1284-1291
Dynamics of plaque formation in Alzheimer's disease
Authors: Urbanc, B Cruz, L Buldyrev, SV Havlin, S Irizarry, MC Stanley, HE Hyman, BT
Citation: B. Urbanc et al., Dynamics of plaque formation in Alzheimer's disease, BIOPHYS J, 76(3), 1999, pp. 1330-1334
Risultati: 1-16 |